Bayer aims to help CureVac with COVID-19 vaccine output, says CEO
German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday.
Related Articles
Bayer CEO wins first AGM shareholder vote
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare…
Ex-McKinsey partner sues firm, claims he was made opioids ‘scapegoat’
A former McKinsey & Co partner sued the global consulting firm on Friday and accused it of defaming him and making him a “scapegoat” to…
CVS Omnicare staff in Las Vegas vote to join new union
Staff at CVS Health’s unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to…
Bayer CEO wins first AGM shareholder vote
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare…
HCA’s unchanged annual forecast clouds better-than-expected quarter
HCA Healthcare on Friday beat Wall Street estimates for quarterly profit and revenue but left its annual forecast unchanged, sending shares of the largest for-profit…
Drugmaker AbbVie expects Humira volume erosion to worsen
AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as…
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer’s gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that…
CVS Omnicare staff in Las Vegas vote to join new union
Staff at CVS Health’s unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to…
Centene’s concerns over Medicare market dull Q1 profit beat
Centene said on Friday its Medicare insurance business would face several challenges next year, taking the sheen off a strong first-quarter earnings report from the…
Bayer CEO wins first AGM shareholder vote
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare…